Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Post-Disaster Support | Emergency Financial Assistance for Self-Financed Cancer Drugs 2025-12-05 14:03
Kelun-Biotech and Crescent Biopharma Announce Strategic Partnership to Develop and Commercialize Novel Oncology Therapeutics 2025-12-04 19:50
Menarini Asia-Pacific Expands Production Facilities, Strengthening Indonesia's Role as Regional Manufacturing Hub 2025-12-04 14:30
Emerald Clinical Appoints Luke Gill as Vice President, Global Head of Oncology, Medical & Scientific Affairs 2025-12-03 21:10
Accord Healthcare Announces Launch of Denosumab∇ - Second Biosimilar in Bone Health 2025-12-02 15:00
Amaran Biotech's Vaccine Adjuvant AB-801 Receives FDA Drug Master File (DMF) Filing Acknowledgement 2025-12-02 14:42
Lynk Pharmaceuticals Announces FDA IND Approval of Its Allosteric TYK2 Inhibitor LNK01006 2025-12-02 08:00
Generate:Biomedicines to Initiate Global Phase 3 Studies of GB-0895, a Long-Acting Anti-TSLP Antibody for Severe Asthma Engineered with AI 2025-12-01 19:00
Lee's Pharm Supports Disaster Relief Efforts for Wang Fuk Court in Tai Po 2025-12-01 18:46
Hedia appoints new CEO: Rasmus Kofoed to succeed Lars Christian Lund 2025-12-01 16:00
The Wisdom Derived from the Great Migration: Hakka Medicine - The Unique "Medical Epic" of the Hakka People 2025-12-01 15:26
Ascletis Selects Its First Oral GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, for Clinical Development 2025-11-30 18:15
The Annals of Oncology Publishes Results of Phase II Study of Sacituzumab Tirumotecan Monotherapy for Urothelial Carcinoma 2025-11-28 12:32
Once-Monthly GLP-1 RA | Gan & Lee Pharmaceuticals Initiates Phase 3 Clinical Study (GRADUAL-3) of the First Chinese Once-Monthly GLP-1 RA for Weight Management 2025-11-27 16:57
IASO Bio Announces BLA Approval of Fucaso (Equecabtagene Autoleucel) by the Hong Kong Department of Health for the Treatment of Relapsed or Refractory Multiple Myeloma 2025-11-27 13:44
Prestige Biopharma and Biosidus Enter Exclusive License Agreement for Tuznue® Commercialization in Latin America 2025-11-26 09:06
Innova Therapeutics to Advance Novel Cancer Treatment with Enci Therapeutics Acquisition 2025-11-25 23:06
Exyte completes Pharmaplan integration: A-to-Z execution in GMP facilities 2025-11-25 18:00
Menarini Group Announces New Data on ELZONRIS® (tagraxofusp-erzs) to be Presented at the 67th American Society of Hematology Annual Meeting and Exposition 2025-11-24 23:34
The Volpi Rosse Menarini: The 'Fantastic Ten' are ready for the 2025 - 2026 Season 2025-11-24 22:40
1 2 3 4 5 280